Funder: American Cancer Society
Due Dates: June 1, 2026 | December 1, 2026
Funding Amounts: Stage I: up to $135,000/year direct costs + 10% indirect (max $297,000 total over 2 years); Stage II: up to $545,000 direct costs + 10% indirect (18 months)
Summary: Supports milestone-driven, innovative cancer research projects translating discoveries to human testing via a two-stage funding model.
Key Information: No prior ACS funding required; open to independent investigators at any career stage.